https://investors.abeonatherapeutics.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_798efd313b61071fa19d384f9817a343/abeonatherapeutics/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://investors.abeonatherapeutics.com/news-events/press-releases/detail/344/abeona-therapeutics-reports-first-quarter-2026-results-and-provides-pipeline-update Wed, 13 May 26 07:30:00 -0400 https://investors.abeonatherapeutics.com/news-events/press-releases/detail/344/abeona-therapeutics-reports-first-quarter-2026-results-and-provides-pipeline-update https://investors.abeonatherapeutics.com/news-events/press-releases/detail/343/abeona-therapeutics-announces-activation-of-childrens-hospital-of-philadelphia-as-a-new-qualified-treatment-center-for-zevaskyn Mon, 11 May 26 08:30:00 -0400 https://investors.abeonatherapeutics.com/news-events/press-releases/detail/343/abeona-therapeutics-announces-activation-of-childrens-hospital-of-philadelphia-as-a-new-qualified-treatment-center-for-zevaskyn https://investors.abeonatherapeutics.com/news-events/press-releases/detail/342/abeona-therapeutics-announces-date-of-first-quarter-financial-results Mon, 04 May 26 08:30:00 -0400 https://investors.abeonatherapeutics.com/news-events/press-releases/detail/342/abeona-therapeutics-announces-date-of-first-quarter-financial-results https://investors.abeonatherapeutics.com/news-events/press-releases/detail/341/abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listing-rule-5635c4 Fri, 01 May 26 08:30:00 -0400 https://investors.abeonatherapeutics.com/news-events/press-releases/detail/341/abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listing-rule-5635c4 https://investors.abeonatherapeutics.com/news-events/press-releases/detail/340/abeona-therapeutics-announces-appointment-of-keith-a-goldan-to-its-board-of-directors Tue, 07 Apr 26 08:30:00 -0400 https://investors.abeonatherapeutics.com/news-events/press-releases/detail/340/abeona-therapeutics-announces-appointment-of-keith-a-goldan-to-its-board-of-directors https://investors.abeonatherapeutics.com/news-events/press-releases/detail/339/abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listing-rule-5635c4 Mon, 06 Apr 26 08:30:00 -0400 https://investors.abeonatherapeutics.com/news-events/press-releases/detail/339/abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listing-rule-5635c4 https://investors.abeonatherapeutics.com/news-events/press-releases/detail/338/abeona-therapeutics-announces-new-qualified-treatment-center-for-zevaskyn-in-new-york Thu, 02 Apr 26 08:30:00 -0400 https://investors.abeonatherapeutics.com/news-events/press-releases/detail/338/abeona-therapeutics-announces-new-qualified-treatment-center-for-zevaskyn-in-new-york https://investors.abeonatherapeutics.com/news-events/press-releases/detail/337/abeona-therapeutics-reports-full-year-2025-financial-results-and-corporate-updates Tue, 17 Mar 26 07:30:00 -0400 https://investors.abeonatherapeutics.com/news-events/press-releases/detail/337/abeona-therapeutics-reports-full-year-2025-financial-results-and-corporate-updates https://investors.abeonatherapeutics.com/news-events/press-releases/detail/336/abeona-therapeutics-provides-business-update-highlighting-building-momentum-in-zevaskyn-commercial-launch Mon, 09 Mar 26 07:30:00 -0400 https://investors.abeonatherapeutics.com/news-events/press-releases/detail/336/abeona-therapeutics-provides-business-update-highlighting-building-momentum-in-zevaskyn-commercial-launch https://investors.abeonatherapeutics.com/news-events/press-releases/detail/335/abeona-therapeutics-announces-date-of-fourth-quarter-full-year-2025-financial-results-and-participation-in-upcoming-2026-leerink-global-healthcare-conference Tue, 03 Mar 26 07:30:00 -0500 https://investors.abeonatherapeutics.com/news-events/press-releases/detail/335/abeona-therapeutics-announces-date-of-fourth-quarter-full-year-2025-financial-results-and-participation-in-upcoming-2026-leerink-global-healthcare-conference